Prescription Pot: More Than a Pipe Dream?

The Supreme Court's ruling against medicinal marijuana isn't chilling a British drugmaker's plans to test an oral spray in the U.S.

That Supreme Court ruling against the medical use of marijuana wasn't a total downer for those who want the weed made legal for treating pain and other ailments. GW Pharmaceuticals, a British company that's developing medications derived from marijuana, says it's pushing ahead with plans to start clinical trials in the U.S., with an eye toward bringing the world's first cannabis-based prescription drug onto the market as early as 2003. In fact, the company announced plans for an initial public offering on May 14, only hours before the high court issued its decision.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.